JP2016523258A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523258A5 JP2016523258A5 JP2016521847A JP2016521847A JP2016523258A5 JP 2016523258 A5 JP2016523258 A5 JP 2016523258A5 JP 2016521847 A JP2016521847 A JP 2016521847A JP 2016521847 A JP2016521847 A JP 2016521847A JP 2016523258 A5 JP2016523258 A5 JP 2016523258A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- crystals
- powder diffraction
- diffraction pattern
- pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361838105P | 2013-06-21 | 2013-06-21 | |
| US61/838,105 | 2013-06-21 | ||
| US201361919424P | 2013-12-20 | 2013-12-20 | |
| US61/919,424 | 2013-12-20 | ||
| PCT/US2014/043422 WO2014205354A2 (en) | 2013-06-21 | 2014-06-20 | Free base crystals |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019104412A Division JP2019189618A (ja) | 2013-06-21 | 2019-06-04 | 遊離塩基結晶 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016523258A JP2016523258A (ja) | 2016-08-08 |
| JP2016523258A5 true JP2016523258A5 (enExample) | 2018-03-08 |
| JP6865036B2 JP6865036B2 (ja) | 2021-04-28 |
Family
ID=52105535
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521847A Active JP6865036B2 (ja) | 2013-06-21 | 2014-06-20 | 遊離塩基結晶 |
| JP2019104412A Pending JP2019189618A (ja) | 2013-06-21 | 2019-06-04 | 遊離塩基結晶 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019104412A Pending JP2019189618A (ja) | 2013-06-21 | 2019-06-04 | 遊離塩基結晶 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9630971B2 (enExample) |
| EP (2) | EP3010509B1 (enExample) |
| JP (2) | JP6865036B2 (enExample) |
| KR (2) | KR102430126B1 (enExample) |
| CN (3) | CN105658222A (enExample) |
| AU (1) | AU2014284224B2 (enExample) |
| BR (1) | BR112015032132B1 (enExample) |
| CA (1) | CA2916393C (enExample) |
| ES (1) | ES2894770T3 (enExample) |
| IL (2) | IL267331B2 (enExample) |
| MX (2) | MX2015017972A (enExample) |
| RU (1) | RU2675851C2 (enExample) |
| WO (1) | WO2014205354A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2717877B1 (en) | 2011-06-10 | 2017-11-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| AR091507A1 (es) * | 2012-06-21 | 2015-02-11 | Intra Cellular Therapies Inc | SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA |
| EP3010509B1 (en) | 2013-06-21 | 2021-07-28 | Intra-Cellular Therapies, Inc. | Free base crystals |
| US12410175B2 (en) | 2019-09-03 | 2025-09-09 | Intra-Cellular Therapies, Inc. | Compounds |
| US12435093B2 (en) | 2020-05-06 | 2025-10-07 | Intra-Cellular Therapies, Inc. | Free base crystals |
| WO2022026417A1 (en) * | 2020-07-26 | 2022-02-03 | Intra-Cellular Therapies, Inc. | Novel uses |
| JP2024531548A (ja) * | 2021-09-03 | 2024-08-29 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 共結晶 |
| WO2023147484A1 (en) * | 2022-01-27 | 2023-08-03 | Intra-Cellular Therapies, Inc. | Novel compositions |
| WO2023147603A2 (en) * | 2022-01-31 | 2023-08-03 | Intra-Cellular Therapies, Inc. | Salt crystals |
| WO2023233410A1 (en) * | 2022-06-02 | 2023-12-07 | Biosight Ltd. | Crystalline form of aspacytarabine intermediate |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| US5471001A (en) * | 1994-12-15 | 1995-11-28 | E. I. Du Pont De Nemours And Company | Crystallization of adipic acid |
| GB9624615D0 (en) * | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Chrystallisation process |
| TWI265925B (en) * | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
| ATE496028T1 (de) * | 2002-02-08 | 2011-02-15 | Ono Pharmaceutical Co | Piperidinderivatverbindungen und arzneimittel, die diese verbindungen als wirkstoff enthalten |
| EP1613747A1 (en) | 2003-03-31 | 2006-01-11 | Pfizer Products Inc. | Crystal structure of 3 ,5 -cyclic nucleotide phosphodiesterase 1b (pde1b) and uses thereof |
| CN100457108C (zh) * | 2003-09-02 | 2009-02-04 | 默克公司 | 一种二肽基肽酶iv抑制剂的磷酸盐新晶体 |
| CN101031548B (zh) * | 2004-09-27 | 2011-04-06 | 阿卡蒂亚药品公司 | N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n'-(4-(2-甲基丙氧基)-苯基甲基)脲的盐及其制备 |
| WO2006133261A2 (en) | 2005-06-06 | 2006-12-14 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2008063505A1 (en) | 2006-11-13 | 2008-05-29 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2008070095A1 (en) | 2006-12-05 | 2008-06-12 | Intra-Cellular Therapies, Inc. | Novel uses |
| EP2939676A1 (en) * | 2007-12-06 | 2015-11-04 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US20120070443A1 (en) | 2008-12-02 | 2012-03-22 | University Of Utah Research Foundation | Pde1 as a target therapeutic in heart disease |
| EA201170769A1 (ru) | 2008-12-06 | 2012-02-28 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| AU2009322903A1 (en) | 2008-12-06 | 2010-06-10 | Intra-Cellular Therapies, Inc. | Organic compounds |
| PE20110922A1 (es) * | 2008-12-06 | 2012-01-22 | Intra Cellular Therapies Inc | DERIVADOS DE PIRAZOLO[4,3-e]PIRIMIDIN COMO INHIBIDORES DE LA FOSFODIESTERASA 1 (PDE1) |
| WO2010098839A1 (en) | 2009-02-25 | 2010-09-02 | Intra-Cellular Therapies, Inc. | Pde 1 inhibitors for ophthalmic disorders |
| EP2434895A4 (en) | 2009-05-13 | 2013-08-07 | Intra Cellular Therapies Inc | ORGANIC CONNECTIONS |
| US8858911B2 (en) | 2009-10-08 | 2014-10-14 | Intra-Cellular Therapies, Inc. | Phosphodiesterase 1-targeting tracers and methods |
| TW201206937A (en) | 2010-05-31 | 2012-02-16 | Intra Cellular Therapies Inc | Organic compounds |
| US9763948B2 (en) | 2010-05-31 | 2017-09-19 | Intra-Cellular Therapies, Inc. | PDE1 inhibitory compounds and methods |
| EP2717877B1 (en) | 2011-06-10 | 2017-11-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| AR091507A1 (es) * | 2012-06-21 | 2015-02-11 | Intra Cellular Therapies Inc | SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA |
| EP3010509B1 (en) | 2013-06-21 | 2021-07-28 | Intra-Cellular Therapies, Inc. | Free base crystals |
-
2014
- 2014-06-20 EP EP14812994.3A patent/EP3010509B1/en active Active
- 2014-06-20 JP JP2016521847A patent/JP6865036B2/ja active Active
- 2014-06-20 US US14/900,589 patent/US9630971B2/en active Active
- 2014-06-20 CN CN201480046150.4A patent/CN105658222A/zh active Pending
- 2014-06-20 IL IL267331A patent/IL267331B2/en unknown
- 2014-06-20 EP EP20165092.6A patent/EP3702358A1/en active Pending
- 2014-06-20 WO PCT/US2014/043422 patent/WO2014205354A2/en not_active Ceased
- 2014-06-20 BR BR112015032132-1A patent/BR112015032132B1/pt active IP Right Grant
- 2014-06-20 MX MX2015017972A patent/MX2015017972A/es active IP Right Grant
- 2014-06-20 AU AU2014284224A patent/AU2014284224B2/en active Active
- 2014-06-20 CA CA2916393A patent/CA2916393C/en active Active
- 2014-06-20 KR KR1020217030964A patent/KR102430126B1/ko active Active
- 2014-06-20 KR KR1020167001273A patent/KR20160040522A/ko not_active Ceased
- 2014-06-20 CN CN201910526464.9A patent/CN110498800A/zh active Pending
- 2014-06-20 CN CN202110144523.3A patent/CN112851683A/zh active Pending
- 2014-06-20 RU RU2016101630A patent/RU2675851C2/ru active
- 2014-06-20 ES ES14812994T patent/ES2894770T3/es active Active
-
2015
- 2015-12-21 MX MX2020001628A patent/MX2020001628A/es unknown
- 2015-12-21 IL IL243269A patent/IL243269B/en active IP Right Grant
-
2019
- 2019-06-04 JP JP2019104412A patent/JP2019189618A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016101630A (ru) | Кристаллические формы свободного основания | |
| EP3237404B1 (en) | Processes for preparing ask1 inhibitors | |
| JP6356876B2 (ja) | 抗ウイルス化合物の合成 | |
| JP2010513494A5 (enExample) | ||
| ES2842123T3 (es) | Purificación de tenofovir alafenamida y sus intermedios | |
| AU2014364410B2 (en) | Process methods for phosphatidylinositol 3-kinase inhibitors | |
| JP2014521726A5 (enExample) | ||
| TW201406763A (zh) | 鹽晶體 | |
| JP2019506379A (ja) | ルキソリチニブの合成プロセス | |
| AR083213A1 (es) | Proceso de preparacion de derivados pirimidinicos, compuestos intermediarios y proceso para prepararlos | |
| ES2604405T3 (es) | Un procedimiento para rilpivirina mejorado | |
| RU2016138800A (ru) | Новый способ получения производных триазина, пиримидина и пиридина | |
| JP2014234517A5 (enExample) | ||
| JP2013518112A5 (enExample) | ||
| US11858928B2 (en) | Process for making palbociclib | |
| JP2012522125A5 (enExample) | ||
| JP2013227573A5 (enExample) | ||
| WO2016058564A1 (en) | Salts of bedaquiline | |
| KR20150117123A (ko) | 블로난세린의 온화한 제조방법 | |
| RU2017110880A (ru) | Способ получения замещенных имидазопиридазинов | |
| EP3133054A1 (de) | Verfahren zur herstellung von symmetrischen pincerliganden aus der gruppe der m-terphenylverbindungen | |
| RU2014153660A (ru) | Способ переработки смесей | |
| DE102015215996A1 (de) | Verfahren zur Herstellung von symmetrischen Pincerliganden aus der Gruppe der m-Terphenylverbindungen | |
| KR20170003261A (ko) | N-(4-아세틸-2,6-디플루오로페닐)메탄술폰아미드의 제조방법 |